UCSF Rosenman ADAPT
$500K* cash support and connections to payers for startups developing breakthrough technologies to improve healthcare efficiency. Deadline to apply is October 1, 2021.
Scale Up Your Healthcare Solution in Partnership with Leading Healthcare Companies
$500K* non-dilutive funding and the opportunity to partner with Anthem, Blue Shield of California, Chicago Pacific Founders, Evernorth & UnitedHealth Group, with over 200 million members. Deadline to apply is October 1, 2021.
*Each selected company receives $100K.
Deadline to apply is October 1, 2021.
UCSF Rosenman ADAPT supports health technology companies who are developing next generation solutions to address health disparities.
As COVID-19 has shown, disparities in health and access to care remain stubbornly intact, and in many ways are widening.
We are interested in bold proposals that can accelerate improvements in health by offering new solutions, and potentially new models, of care. We are particularly interested in interventions that can improve health outcomes at the population/community-level.
A minimum viable product is essential. Solutions could include, but are not limited to:
- Multi-sectorial interventions that address social and economic determinants of health across multiple domains at the intersection of social, economic, and health needs.
- Improving health care access, potentially with new forms of delivery.
- Whole-person models of care that support integration of behavioral and medical drivers of health status.
- Improving engagement of diverse communities with their health, with providers, and with payers.
- Interventions that help unwind racial bias in healthcare decision-making.
We encourage proposals from companies run by, or for, women, communities of color and LGBTQ communities. It is important for companies, especially companies not led by the constituents they seek to serve, to display a collaborative, community-driven approach.
You should demonstrate in your proposal the following:
- Connections to the community you serve that demonstrate effective engagement and trust.
- Understanding of the community you serve, including their unique cultural values, their particular social and health needs, and the lived experiences of community members.
- How you will be inclusive of community voices and knowledge when it comes to prototyping and co-creating your initiative.
- Proposed solutions that build on and support existing community strengths.
- Applicants must show their solutions are innovative and have the potential to be deployed on a national scale.
- If selected, applicants must commit to provide staff, time, and resources to validate, pilot, and deploy the solution that is being developed.
- Companies from early stage with MVP to late stage (revenue) are eligible.
- Companies based anywhere in the world are eligible.
Got a question? Please see FAQ.
Areas of Interest
This is not a complete listing. Other proposed solutions are welcome.
- Mental & Behavioral Health Solutions
- Elderly Care Solutions
- Women’s Health
- Cardiovascular Care
- Oncology Care
- Chronic Care
- Virtual Care
- Pharmacy Remote Solutions
- Autoimmune Disease
- Hospital at home
- Infectious Disease
- Digital Therapeutics
- Care at Home
- Patient & Family Support
- Pain Management
- AI/DSS that prevent bias
By the UCSF Rosenman Institute and corporate partners of the ADAPT program.
- Remote participation – all presentations are virtual
- Cash $100K non-dilutive funding
- Fast turnaround time
- Insights on how to implement which data are key, and what pilot environment is optimal
- Access to data and HIPAA compliant infrastructure
- Exposure to strategic and venture capital investors
What our startups said about this program
“I highly recommend entering the ADAPT Program to any innovative startup! Winning a proof-of-concept opportunity with a leading healthcare company via ADAPT 2020 was a pivotal moment for Oshi Health. The clinical study we have launched with our sponsor will prove the value of our virtual-first gastroenterology clinic relative to traditional GI care delivery.”
“Our experience with the Rosenman ADAPT program was exceptional. From the first step (a reasonably short and to the point application, which is rare for opportunities like these), to the periodic updates as we moved through the stages, to the insights and feedback offered during our pitch opportunities, the value for ConsejoSano in working with the Rosenman Institute has been tangible. We’ve already connected with two large potential health plan clients which I expect will lead to significant revenue opportunities for us. I would recommend the ADAPT program to any healthtech company that is ready to grow on a bigger stage.”
“We are delighted to have the opportunity to work with the key healthcare partners through the ADAPT program, and grateful for the impact the $150,000 grant has had on accelerating our technology development. The ADAPT program has supported Emme in our ability to reach patients more quickly and on a broader scale, which is especially meaningful in the context of the unprecedented demand the past year has shown for women’s digital health support.”
Our company is at a later stage with a product on the market. Are we eligible?
I am working on technology without a formalized/incorporated company. Can I apply to ADAPT?
In order to work with our partners, it would make sense for your entities to be incorporated already.
We are not officially formed as a company and have a proposal that would be under proof of concept. In addition, all of us have full-time jobs in different companies. Would this prevent us from being able to work in our roles as well as this concept in the case that our concept is picked?
We want a team that is fully dedicated to the project. A project is not eligible if the leadership is part-time.
My company is based outside the United States. Are we eligible to be selected?
Must the area of implementation be in the USA?
Not necessarily. We are looking for solutions that can be implemented inside or outside the USA.
If selected, will the small company still own all of the intellectual property rights?
The UCSF Rosenman Institute does not get involved in the IP at all. In ADAPT we connect the emerging companies with the larger partners. Existing IP remains the property of the startup, while any IP developed as part of working with the larger partner may be subject to a separate agreement with them.